Sigma Healthcare posts strong FY25 growth after Chemist Warehouse merger

Sigma Healthcare Limited reported a robust financial year ended 30 June 2025, with statutory revenue increasing 82% year-on-year to $6.0 bn and normalised EBIT rising 41.4% to $834.5 m. The successful merger with Chemist Warehouse Group in February 2025 created Australia's leading retail pharmacy franchisor and full-line pharmaceutical wholesaler, with a network of almost 900 Australian franchise stores and over 80 international stores.

The company's retail network sales, including Chemist Warehouse, grew 14% to $10 bn, driven by strong trading momentum and 35 new store openings. The synergy target from the merger has been upgraded from $60 m to $100 m per annum.

Sigma also confirmed a fully franked final dividend of 1.3 cents per share, reflecting strong financial performance and prudent capital management. The company is committed to sustainable growth, supported by a net debt position of $752.2 m (0.85x Normalised EBITDA).